chalcone has been researched along with Chronic Illness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avril, L; Boussetta, S; Enriquez Vega, DM; Guex, JJ; Taïeb, C | 1 |
| Dong, H; Guo, J; Li, X; Liu, J; Niu, Y; Zhang, Y; Zhao, X; Zhou, L | 1 |
| He, H; Li, L; Shi, M; Wu, L; Yang, J; Yang, X; Zeng, X | 1 |
| Kishimoto, S; Kosakai, K; Matsumoto, M; Mochizuki, S; Tomiyama, A; Wakabayashi, S | 1 |
1 trial(s) available for chalcone and Chronic Illness
| Article | Year |
|---|---|
Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment - 'QUALITY Study'.
Topics: Administration, Oral; Adult; Ascorbic Acid; Body Mass Index; Chalcone; Chronic Disease; Drug Therapy, Combination; Female; Hesperidin; Humans; Male; Mexico; Middle Aged; Obesity; Plant Extracts; Prospective Studies; Quality of Life; Ruscus; Surveys and Questionnaires; Vascular Diseases | 2009 |
3 other study(ies) available for chalcone and Chronic Illness
| Article | Year |
|---|---|
Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Chalcone; Chronic Disease; Collagen Type I; Gene Expression Regulation, Enzymologic; Hepatic Stellate Cells; Liver Cirrhosis; Male; Matrix Metalloproteinase 9; Phosphorylation; Quinones; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad4 Protein; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2011 |
Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats.
Topics: Acute Disease; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Viscosity; Cardiotonic Agents; Chalcone; Chronic Disease; Coronary Vessels; Creatine Kinase; Diltiazem; Disease Models, Animal; Echocardiography; Endothelin-1; Heart Failure; Hemodynamics; L-Lactate Dehydrogenase; Ligation; Malondialdehyde; Nitric Oxide Synthase; Oxidative Stress; Quinones; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2008 |
Therapeutic effect of egualen sodium (KT1-32), a new antiulcer agent, on chronic gastritis induced by sodium taurocholate in rats.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Anti-Ulcer Agents; Azulenes; Cell Count; Cell Division; Chalcone; Chalcones; Chronic Disease; Dose-Response Relationship, Drug; Gastric Mucosa; Gastritis; Male; Mucus; Parietal Cells, Gastric; Rats; Rats, Wistar; Sesquiterpenes; Sesquiterpenes, Guaiane; Taurocholic Acid; Treatment Outcome | 1996 |